(Q44405249)

2 December 2017

title

Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma (English)

1 reference

2 December 2017

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

24 December 2023

0 references

0 references

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

24 December 2023

author name string

Dong-M Shin

2

1 reference

2 December 2017

Uwe Keppler

5

1 reference

2 December 2017

Christian Manegold

6

1 reference

2 December 2017

Howard Burris

7

1 reference

2 December 2017

Ulrich Gatzemeier

8

1 reference

2 December 2017

Johannes Blatter

9

1 reference

2 December 2017

Giorgio V. Scagliotti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697881

24 December 2023

Hedy L. Kindler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697881

24 December 2023

Michael J. Vasconcelles

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697881

24 December 2023

James T. Symanowski

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697881

24 December 2023

James J. Rusthoven

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697881

24 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

15 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12697881

full work available at URL

24 December 2023

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.06.122

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Journal of Clinical Oncology

24 December 2023

published in

1 reference

2 December 2017

volume

21

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

1556-1561

1 reference

Journal impact factors for 1999

2 December 2017

cites work

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1136/THORAX.55.9.725

Malignant pleural mesothelioma

13 November 2021

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Continuing increase in mesothelioma mortality in Britain.

24 December 2023

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Chemotherapy in malignant pleural mesothelioma. A review.

24 December 2023

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II study

24 December 2023

5

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study

24 December 2023

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group

24 December 2023

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234.

24 December 2023

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors

24 December 2023

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

One-sample multiple testing procedure for phase II clinical trials

24 December 2023

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

A Comparison of Approximate Interval Estimators for the Bernoulli Parameter

24 December 2023

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Nonparametric Estimation from Incomplete Observations

24 December 2023

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

The alpha folate receptor is highly activated in malignant pleural mesothelioma

24 December 2023

19

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin

24 December 2023

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma

24 December 2023

22

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer

24 December 2023

25

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group

24 December 2023

26

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer

24 December 2023

27

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer

24 December 2023

28

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study

24 December 2023

29

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

24 December 2023

31

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.06.122

24 December 2023

Identifiers

1 reference

2 December 2017

1 reference